Triton Partners, is considering a takeover bid Evotec , Eyk Henning of Bloomberg reported earlier, citing people familiar with the matter. Triton is among several investment firms

Update 1:50pm: Updates shares, adds further details. Evotec SE (NASDAQ:EVO) ADRs surged 18% after a report that Triton Partners is considering a takeover offer for the German drug developer. Triton is among one of several investment companies that have ...

Evotec shares soared after the company said private equity group Triton had acquired about 10% of its stock. Luxembourg-based private equity firm Triton acquired a total of 17,730,913 ordinary shares in a series of transactions totaling 131 million euros ($140.4 million), the German biotechnology company said.

Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed private equity firm Triton had built an over 9% stake in the German drug development company. Evotec confirmed to Reuters that Triton now holds a 9.